- Page 1: Adverse DrugEffectsA Nursing Concer
- Page 6 and 7: © 2000 Whurr PublishersFirst publi
- Page 8 and 9: viAdverse Drug Effects: a nursing c
- Page 11 and 12: PrefaceNurses have always had to ha
- Page 13 and 14: IntroductionThis book is not intend
- Page 15: PART 1THE SCIENCE OFADVERSE DRUG EF
- Page 18 and 19: 4 Adverse Drug Effects: a nursing c
- Page 20 and 21: 6 Adverse Drug Effects: a nursing c
- Page 22 and 23: 8 Adverse Drug Effects: a nursing c
- Page 24 and 25: 10 Adverse Drug Effects: a nursing
- Page 26: 12 Adverse Drug Effects: a nursing
- Page 29 and 30: Pharmacokinetic effects - absorptio
- Page 31 and 32: Pharmacokinetic effects - absorptio
- Page 33 and 34: Pharmacokinetic effects - absorptio
- Page 35 and 36: Pharmacokinetic effects - absorptio
- Page 37 and 38: Pharmacokinetic effects - absorptio
- Page 39 and 40: Pharmacokinetic effects - metabolis
- Page 41 and 42: Pharmacokinetic effects - metabolis
- Page 43 and 44: Pharmacokinetic effects - metabolis
- Page 45 and 46: Pharmacokinetic effects - metabolis
- Page 47 and 48: Pharmacokinetic effects - metabolis
- Page 49 and 50: Pharmacokinetic effects - metabolis
- Page 51 and 52: Chapter 3Pharmacodynamics andrecept
- Page 53 and 54:
Pharmacodynamics and receptors 39mu
- Page 55 and 56:
Pharmacodynamics and receptors 41pr
- Page 57 and 58:
Pharmacodynamics and receptors 43Re
- Page 59 and 60:
Pharmacodynamics, enzymes, ion chan
- Page 61 and 62:
Pharmacodynamics, enzymes, ion chan
- Page 63 and 64:
Pharmacodynamics, enzymes, ion chan
- Page 65 and 66:
Pharmacodynamics, enzymes, ion chan
- Page 67 and 68:
Idiosyncratic effects and drug alle
- Page 69 and 70:
Idiosyncratic effects and drug alle
- Page 71 and 72:
Idiosyncratic effects and drug alle
- Page 73 and 74:
Idiosyncratic effects and drug alle
- Page 75 and 76:
Idiosyncratic effects and drug alle
- Page 77 and 78:
Idiosyncratic effects and drug alle
- Page 79 and 80:
Idiosyncratic effects and drug alle
- Page 81 and 82:
Chapter 6Client groupsIntroductionD
- Page 83 and 84:
Client groups 69British National Fo
- Page 85 and 86:
Client groups 71Formulary Appendix
- Page 87 and 88:
Client groups 73times at the expens
- Page 89 and 90:
Client groups 75Many factors alter
- Page 91 and 92:
Client groups 77the neonate followi
- Page 93 and 94:
Client groups 79excretion for termi
- Page 95 and 96:
Client groups 81• inappropriate p
- Page 97 and 98:
Client groups 83microvilli and dimi
- Page 99 and 100:
Client groups 85tion is to measure
- Page 101 and 102:
Client groups 87Table 6.11 (contd)D
- Page 103 and 104:
Client groups 89Planchock NY, Slay
- Page 105 and 106:
Gastro-intestinal and hepatic effec
- Page 107 and 108:
Gastro-intestinal and hepatic effec
- Page 109 and 110:
Gastro-intestinal and hepatic effec
- Page 111 and 112:
Gastro-intestinal and hepatic effec
- Page 113 and 114:
Gastro-intestinal and hepatic effec
- Page 115 and 116:
Gastro-intestinal and hepatic effec
- Page 117 and 118:
Gastro-intestinal and hepatic effec
- Page 119 and 120:
Gastro-intestinal and hepatic effec
- Page 121 and 122:
Gastro-intestinal and hepatic effec
- Page 123 and 124:
Gastro-intestinal and hepatic effec
- Page 125 and 126:
Chapter 8Renal effectsThe kidneys p
- Page 127 and 128:
Renal effects 113further potassium
- Page 129 and 130:
Renal effects 115Total renal failur
- Page 131 and 132:
Renal effects 117Tubular toxicityRe
- Page 133 and 134:
Renal effects 119Table 8.4 Clinical
- Page 135 and 136:
Renal effects 121and circulating an
- Page 137 and 138:
Renal effects 123below 5.6, as is f
- Page 139 and 140:
Renal effects 125be removed by dial
- Page 141 and 142:
Renal effects 127Skinner S (1996) U
- Page 143 and 144:
Cardiovascular and respiratory effe
- Page 145 and 146:
Cardiovascular and respiratory effe
- Page 147 and 148:
Cardiovascular and respiratory effe
- Page 149 and 150:
Cardiovascular and respiratory effe
- Page 151 and 152:
Cardiovascular and respiratory effe
- Page 153 and 154:
Cardiovascular and respiratory effe
- Page 155 and 156:
Cardiovascular and respiratory effe
- Page 157 and 158:
Cardiovascular and respiratory effe
- Page 159 and 160:
Cardiovascular and respiratory effe
- Page 161 and 162:
Cardiovascular and respiratory effe
- Page 163 and 164:
Cardiovascular and respiratory effe
- Page 165 and 166:
Neurological, sensory and endocrine
- Page 167 and 168:
Neurological, sensory and endocrine
- Page 169 and 170:
Neurological, sensory and endocrine
- Page 171 and 172:
Neurological, sensory and endocrine
- Page 173 and 174:
Neurological, sensory and endocrine
- Page 175 and 176:
Neurological, sensory and endocrine
- Page 177 and 178:
Neurological, sensory and endocrine
- Page 179 and 180:
Neurological, sensory and endocrine
- Page 181 and 182:
Neurological, sensory and endocrine
- Page 183 and 184:
Neurological, sensory and endocrine
- Page 185 and 186:
Neurological, sensory and endocrine
- Page 187 and 188:
Psychological effects 173mental sta
- Page 189 and 190:
Psychological effects 175dopa, whic
- Page 191 and 192:
Psychological effects 177malarial p
- Page 193 and 194:
Psychological effects 179Symptoms o
- Page 195 and 196:
Psychological effects 181dopamine-p
- Page 197 and 198:
Psychological effects 183fore decre
- Page 199 and 200:
Psychological effects 185Lehane M,
- Page 201 and 202:
Effects on the skin and musculoskel
- Page 203 and 204:
Effects on the skin and musculoskel
- Page 205 and 206:
Effects on the skin and musculoskel
- Page 207 and 208:
Effects on the skin and musculoskel
- Page 209 and 210:
Effects on the skin and musculoskel
- Page 211 and 212:
Effects on the skin and musculoskel
- Page 213 and 214:
Effects on the skin and musculoskel
- Page 215 and 216:
Effects on the skin and musculoskel
- Page 217 and 218:
Effects on the reproductive system
- Page 219 and 220:
Effects on the reproductive system
- Page 221 and 222:
Effects on the reproductive system
- Page 223 and 224:
Effects on the reproductive system
- Page 225 and 226:
Effects on the reproductive system
- Page 227 and 228:
Effects on the reproductive system
- Page 229 and 230:
Chapter 14Drug resistanceBacterial
- Page 231 and 232:
Drug resistance 217between bacteria
- Page 233 and 234:
Drug resistance 219in permeability
- Page 235 and 236:
Drug resistance 221Prevention of ba
- Page 237 and 238:
Drug resistance 223Research has sho
- Page 239:
PART 2THE ART OF ADVERSEDRUG EFFECT
- Page 242 and 243:
228 Adverse Drug Effects: a nursing
- Page 244 and 245:
230 Adverse Drug Effects: a nursing
- Page 246 and 247:
232 Adverse Drug Effects: a nursing
- Page 248 and 249:
234 Adverse Drug Effects: a nursing
- Page 250 and 251:
236 Adverse Drug Effects: a nursing
- Page 252 and 253:
238 Adverse Drug Effects: a nursing
- Page 254 and 255:
240 Adverse Drug Effects: a nursing
- Page 256 and 257:
242 Adverse Drug Effects: a nursing
- Page 258 and 259:
244 Adverse Drug Effects: a nursing
- Page 260 and 261:
246 Adverse Drug Effects: a nursing
- Page 262 and 263:
248 Adverse Drug Effects: a nursing
- Page 264 and 265:
250 Adverse Drug Effects: a nursing
- Page 266 and 267:
Chapter 17Compliance, patienteducat
- Page 268 and 269:
254 Adverse Drug Effects: a nursing
- Page 270 and 271:
256 Adverse Drug Effects: a nursing
- Page 272 and 273:
258 Adverse Drug Effects: a nursing
- Page 274 and 275:
260 Adverse Drug Effects: a nursing
- Page 276 and 277:
262 Adverse Drug Effects: a nursing
- Page 278 and 279:
264 Adverse Drug Effects: a nursing
- Page 280 and 281:
266 Adverse Drug Effects: a nursing
- Page 282 and 283:
Chapter 18Complementary therapyDEBR
- Page 284 and 285:
270 Adverse Drug Effects: a nursing
- Page 286 and 287:
272 Adverse Drug Effects: a nursing
- Page 288 and 289:
274 Adverse Drug Effects: a nursing
- Page 290 and 291:
276 Adverse Drug Effects: a nursing
- Page 292 and 293:
278 Adverse Drug Effects: a nursing
- Page 294 and 295:
280 Adverse Drug Effects: a nursing
- Page 296 and 297:
282 Adverse Drug Effects: a nursing
- Page 298 and 299:
284 Adverse Drug Effects: a nursing
- Page 301 and 302:
Chapter 19Assessment issuesInaccura
- Page 303 and 304:
Assessment issues 289Most elderly p
- Page 305 and 306:
Assessment issues 291stimulant. Mr
- Page 307 and 308:
Assessment issues 293and multiple s
- Page 309 and 310:
Assessment issues 295Finally, a key
- Page 311 and 312:
Chapter 20Drug interactionsPolyphar
- Page 313 and 314:
Drug interactions 299providers. Mrs
- Page 315 and 316:
Drug interactions 301Over-the-count
- Page 317 and 318:
Drug interactions 303not seen until
- Page 319 and 320:
Drug interactions 305Saunders has n
- Page 321 and 322:
Drug interactions 307• What might
- Page 323 and 324:
Drug interactions 309Ariyaratnam S,
- Page 325 and 326:
Drug misuse 311• How could her de
- Page 327 and 328:
Drug misuse 313onists of calcium ca
- Page 329 and 330:
Drug misuse 315Marjorie has an eye
- Page 331 and 332:
Drug misuse 317was unwell had been
- Page 333 and 334:
Drug misuse 319inflammatory respons
- Page 335 and 336:
Drug misuse 321tablets hidden in th
- Page 337 and 338:
Chapter 22EmpowermentAllowing choic
- Page 339 and 340:
Empowerment 325Table 22.1 The advan
- Page 341 and 342:
Empowerment 327It is generally agre
- Page 343 and 344:
Empowerment 329Table 22.2 Possible
- Page 345 and 346:
Empowerment 331ban or legalize cann
- Page 347 and 348:
Empowerment 333drugs that could be
- Page 349 and 350:
Empowerment 335Paganini-Hill A, Ros
- Page 351 and 352:
Abbreviations and Glossary 337Angio
- Page 353 and 354:
Abbreviations and Glossary 339Nysta
- Page 355 and 356:
Indexabsorption 9-16, 73-76, 82-83a
- Page 357 and 358:
Index 343128, 130, 133, 135, 143-14
- Page 359 and 360:
Index 345elderly 79-87elimination 3
- Page 361 and 362:
Index 347libido 203-204licensing 24
- Page 363 and 364:
Index 349phenolphthalein 210phenoth
- Page 365:
Index 351tissue binding 18-19tolbut